paliperidone palmitate ER

Trials studying paliperidone palmitate ER

• N/AA Bioequivalence Study of PP3M in Patients With Schizophreniarecruitingn=260
• N/ABioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With Schizophreniacompletedn=256
• phase3A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniformcompletedn=337
• phase4A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settingscompletedn=93
• —A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugalcompletedn=55
• —A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthlycompletedn=225
• phase4A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilitiescompletedn=34
• phase3A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulationcompletedn=306